-
That’s all for
#OCTDACH ! This event was a great success and we are so happy to have had so many great conversations.. Safe travels home! http://bit.ly/317ezVT pic.twitter.com/sQKceWQM9v
-
It’s not too late to stop by Booth 1! Stop by to learn how ERT can minimize uncertainties in your clinical trials!
#OCTDACH http://bit.ly/2olW430 pic.twitter.com/yr35pmpw9w
-
ERT provides the right technology for each study - head over to Booth 1 to hear how we can assist you before attending the networking lunch!
#OCTDACH http://bit.ly/2M3cBBN pic.twitter.com/R3rKvJ7NzI
-
Want a chance to win an
#AppleWatch at#OCTDACH? Stop by our Myoderm booth where James, Karolina, and Tom are collecting business cards to choose a winner at random!@ArenaIntOCT#Myoderm#ClinicalTrials#Giveaway -
Learn why half of all FDA approvals are supported by ERT’s eClinical solutions
#OCTDACH - Booth 1 http://bit.ly/2IDrAR0 pic.twitter.com/Tlvti80Ctc
-
Are you at
#OCTDACH? Meet our team, Caro Barth and Alexandra Berner to explore mutual business opportunities!#conferences#clinicatrials#businessdevelopmentpic.twitter.com/wI1257ZlVv
-
Good Morning,
#OCTDACH! Visit the ERT booth to learn how our eclinical solutions can help you minimize risk in your next trial. Booth 1! http://bit.ly/2IASxoa pic.twitter.com/LCttaZtFWh
-
James, Karolina, and Tom earlier today at
#OCTDACH in Munich! Be sure to stop by tomorrow to learn more about our services and clinical trial solutions.#Myoderm#ClinicalTrials#Pharmapic.twitter.com/035PyOMUPt
-
Great first day at
#OCTDACH in#Munich. The#exhibition represents the entire portfolio of service providers for#clinicaltrials. 200 participants with a high prevalence from#Biotech, but also#Pharma. Great start for a whole series of#conferences this#fall@ArenaIntOCTpic.twitter.com/oByrbN0Lh7
-
Come visit booth #19 at
#OCTDACH, in Munich, Germany! Edwin and Reinhardt are ready to discuss how QPS can provide you with custom-built research solutions for your next#clinicaltrial! To learn more about QPS, visit http://qps.com , or email info@qps.com#QPSLLCpic.twitter.com/BmlvSvDX3O
-
Learn why half of all FDA approvals are supported by ERT’s eClinical solutions
#OCTDACH Booth1 http://bit.ly/2ASVZGu pic.twitter.com/W8HRXmnTOU
-
TODAY at LUNCH! Visit
@ERTglobal: booth #1 to learn how our automated imaging solution can transform your next clinical trial.#OCTDACH http://bit.ly/312YRv4 pic.twitter.com/OOT8wbKYVd
-
TODAY @ LUNCH! Visit booth #1 to learn how our automated imaging solution can transform your next clinical trial.
#OCTDACH http://bit.ly/312YRv4 pic.twitter.com/dz5KyCPQE9
-
Come say hi to us at
#OCTDACH today and tomorrow at booth 18 to learn more about our clinical research organization (#CRO). You can also check out our website at http://sourcia.eu . See you soon!https://twitter.com/ArenaIntOCT/status/1180784932215504896 …
-
#OCTDACH is upon us and our European team is on site in Munich and ready to talk about how we can provide you with a#BetterClinicalExperience! Please fill out this brief form in the attached to request a meeting: https://hubs.ly/H0l6dGY0 pic.twitter.com/kidhozjVSP
-
Stop by Booth 1 to learn how ERT can help your next clinical trial.
#OCTDACH http://bit.ly/2OymF7I pic.twitter.com/tJBqCEUrTY
-
Good morning from Munich! Stop by booth 23 at
#OCTDACH today to chat with Mandy Higgins and Dan Jones about your next#clinicaltrial and how we can partner for success.@ArenaIntOCT#centrallabpic.twitter.com/B4nLeUy1p1
-
Good morning, Munich!
#OCTDACH is about to start! Grab your coffee & get ready for a great conference. Look out for ERT at Booth 1! http://bit.ly/312Aa1H pic.twitter.com/yyMY1dQkmk
-
Stop by Booth 1
#OCTdach and discover why ERT has been a trusted provider for clinical endpoint data collection, predictive analytics, and real world evidence in over 15,000 clinical trials. https://ert.co/2IyuTsu pic.twitter.com/UbH5cjN9rO
-
Tomorrow starts the Outsourcing in Clinical Trials DACH conference in Munich! Tom Gregson and Karolina Shaw will be in attendance, as well as our CEO, James Lovett.
#OCTDACH@ArenaIntOCT
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.